Mendus AB (publ) (IMMU.ST)

SEK 8.51

(-1.06%)

Gross Profit Summary of Mendus AB (publ)

  • Mendus AB (publ)'s latest annual gross profit in 2023 was 28.48 Million SEK , up 1297.19% from previous year.
  • Mendus AB (publ)'s latest quarterly gross profit in 2024 Q2 was -1.01 Million SEK , down -46.35% from previous quarter.
  • Mendus AB (publ) reported a annual gross profit of -1.85 Million SEK in annual gross profit 2022, down -0.43% from previous year.
  • Mendus AB (publ) reported a annual gross profit of -1.84 Million SEK in annual gross profit 2021, down -3.94% from previous year.
  • Mendus AB (publ) reported a quarterly gross profit of -1.01 Million SEK for 2024 Q2, down -46.35% from previous quarter.
  • Mendus AB (publ) reported a quarterly gross profit of -3.18 Million SEK for 2023 Q3, down 0.0% from previous quarter.

Annual Gross Profit Chart of Mendus AB (publ) (2023 - 2009)

Historical Annual Gross Profit of Mendus AB (publ) (2023 - 2009)

Year Gross Profit Gross Profit Growth
2023 28.48 Million SEK 1297.19%
2022 -1.85 Million SEK -0.43%
2021 -1.84 Million SEK -3.94%
2020 -1.77 Million SEK -111.81%
2019 15.03 Million SEK 25153.33%
2018 -60 Thousand SEK 15.72%
2017 -71.19 Thousand SEK 11.89%
2016 -80.79 Thousand SEK 0.0%
2015 - SEK 100.0%
2014 -83.8 Thousand SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 100.0%
2011 -2.69 Million SEK 0.0%
2010 - SEK 0.0%
2009 - SEK 0.0%

Peer Gross Profit Comparison of Mendus AB (publ)

Name Gross Profit Gross Profit Difference
Alligator Bioscience AB (publ) -160.68 Million SEK 117.728%
Ziccum AB (publ) -23.28 Million SEK 222.335%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 346.31 Million SEK 91.774%
Sprint Bioscience AB (publ) 41.78 Million SEK 31.828%
Genovis AB (publ.) 54 Million SEK 47.247%
Intervacc AB (publ) -13.79 Million SEK 306.517%
QuiaPEG Pharmaceuticals Holding AB (publ) 2.17 Million SEK -1212.16%
Active Biotech AB (publ) -1.67 Million SEK 1800.716%
Magle Chemoswed Holding AB (publ) 9.96 Million SEK -185.928%
Bio-Works Technologies AB (publ) 26.82 Million SEK -6.212%
Aptahem AB (publ) 2.63 Million SEK -982.889%
Vicore Pharma Holding AB (publ) -3.42 Million SEK 932.71%
Kancera AB (publ) -1.96 Million SEK 1549.72%
Infant Bacterial Therapeutics AB (publ) 77 Thousand SEK -36896.104%
Fluicell AB (publ) 1.73 Million SEK -1539.068%
Saniona AB (publ) 11.78 Million SEK -141.805%
Lipigon Pharmaceuticals AB (publ) -5.11 Million SEK 656.713%
Biovica International AB (publ) 6.87 Million SEK -314.236%
Spago Nanomedical AB (publ) -23.28 Million SEK 222.351%
AcouSort AB (publ) 8.38 Million SEK -239.576%
Xintela AB (publ) 78 Thousand SEK -36421.795%
Abliva AB (publ) -35.66 Million SEK 179.878%
Egetis Therapeutics AB (publ) -146.9 Million SEK 119.392%
Karolinska Development AB (publ) 2.8 Million SEK -914.856%
OncoZenge AB (publ) 3000.00 SEK -949466.667%
Amniotics AB (publ) -1.93 Million SEK 1576.01%
2cureX AB (publ) -37.48 Million SEK 175.992%
CombiGene AB (publ) -21.29 Million SEK 233.8%
Asarina Pharma AB (publ) -423 Thousand SEK 6834.515%
Calliditas Therapeutics AB (publ) 1.12 Billion SEK 97.479%
Camurus AB (publ) 1.58 Billion SEK 98.198%
Corline Biomedical AB 28.38 Million SEK -0.377%
IRLAB Therapeutics AB (publ) -122.73 Million SEK 123.21%
Isofol Medical AB (publ) -34.41 Million SEK 182.775%
I-Tech AB 27.56 Million SEK -3.341%
Hansa Biopharma AB (publ) 70.95 Million SEK 59.85%
Cyxone AB (publ) 2.61 Million SEK -991.038%
ExpreS2ion Biotech Holding AB (publ) 3.4 Million SEK -737.114%
Biosergen AB -456 Thousand SEK 6347.149%
Cantargia AB (publ) -3.45 Million SEK 925.471%
NextCell Pharma AB -43.74 Million SEK 165.116%
Xspray Pharma AB (publ) -9.19 Million SEK 409.843%
Elicera Therapeutics AB (publ) 11.21 Million SEK -153.934%
Nanologica AB (publ) -76 Thousand SEK 37582.895%
SynAct Pharma AB -778 Thousand SEK 3761.568%
Annexin Pharmaceuticals AB (publ) -193 Thousand SEK 14860.104%
Stayble Therapeutics AB (publ) - SEK -Infinity%
LIDDS AB (publ) -12.92 Million SEK 320.453%
Lipum AB (publ) 53 Thousand SEK -53649.057%
BioInvent International AB (publ) 71.46 Million SEK 60.136%
Alzinova AB (publ) 19.87 Million SEK -43.338%
Oncopeptides AB (publ) 36.29 Million SEK 21.521%
Pila Pharma AB (publ) 1.46 Million SEK -1847.137%
Guard Therapeutics International AB (publ) -15 Thousand SEK 190013.333%
Scandinavian ChemoTech AB (publ) 1.65 Million SEK -1618.154%
Simris Alg AB (publ) 2 Million SEK -1319.382%
Diamyd Medical AB (publ) -3.58 Million SEK 895.726%
Xbrane Biopharma AB (publ) 35.38 Million SEK 19.501%
Ascelia Pharma AB (publ) -1.04 Million SEK 2815.634%
Diagonal Bio AB (publ) 3.13 Million SEK -809.256%